LIPT2-AS1 Antibody (OTI4C7) [DyLight 755]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-71949IR
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot
Label
DyLight 755 (Excitation = 754 nm, Emission = 776 nm)
Antibody Source
Monoclonal Mouse IgG1 Clone # OTI4C7
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Full length recombinant protein of human Cytochrome c (NP_940921) produced in E.coli.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for LIPT2-AS1 Antibody (OTI4C7) [DyLight 755]
Application
Recommended Usage
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: LIPT2-AS1
Alternate Names
LIPT2 antisense RNA 1, MGC12965
Gene Symbol
LIPT2-AS1
Additional LIPT2-AS1 Products
Product Documents for LIPT2-AS1 Antibody (OTI4C7) [DyLight 755]
Product Specific Notices for LIPT2-AS1 Antibody (OTI4C7) [DyLight 755]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...